Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA declines year over year
Q2 FY2026 EBITDA of $61.59M fell 55.1% year over year, behind the -17.8% change in trailing-twelve-month EBITDA. Sequentially, it fell 49.1% from the prior quarter. Over 3 fiscal years it compounded at +28.2% a year.
Context
- EBITDA amounted to 59.0% of revenue in FY2025, up 0.3 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $373.71M (-18.2%) for the fiscal year ending Dec 2026, a slowdown from the +10.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $61.59M-49.1% QoQ
- Last fiscal yearDec 2025
- $456.83M+10.7% YoY
- LTMJun 2026
- $390.9M-17.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -55.1% | +47.2% | +102.3 pp |
| 1 year | +10.7% | -18.2% | -28.9 pp |
| 3-year CAGR | +28.2% | -0.8% | -29.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 456.83M USD
- Year-over-year change
- +10.7%
- 4-year CAGR
- +28.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 456.83M | +10.7% |
| FY2024 | 2024-12-31 | 412.61M | +32.3% |
| FY2023 | 2023-12-31 | 311.81M | +43.8% |
| FY2022 | 2022-12-31 | 216.89M | +30.5% |
| FY2021 | 2021-12-31 | 166.21M | — |
EBITDA vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 EBITDA of $390.9M is the 8th highest of the 11 companies compared; the peer median is $699.52M.
- Its year-over-year change of -17.8% is the lowest of 9, against a peer median of +47.6%.
- EBITDA amounts to 45.5% of revenue for SBRA, versus a peer median of 53.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.33B | -5.4% | +4.2% | 24.3% | |
| LTM Sep 2026 | $1.76B | +15.8% | +1.1% | 78.5% | |
| LTM Jun 2026 | $1.45B | +41.6% | +5.3% | 112.1% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $1.05B | +979.1% | -31.2% | 103.2% |
| LTM Sep 2026 | $851.29M | +205.9% | +16.4% | 186.2% | |
| LTM Sep 2026 | $547.75M | +45.6% | +85.1% | 89.0% | |
| LTM Sep 2026 | $482.47M | +49.6% | +15.4% | 18.1% | |
| LTM Jun 2026 | $390.9M | -17.8% | +28.2% | 45.5% | |
| FY2025 | $211.75M | — | — | 27.5% | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $84.36M | — | +14.7% | 24.6% |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $73.51M | +495.0% | +15.1% | 21.5% |
| Peer median (excluding SBRA) | $699.52M | +47.6% | +14.7% | 53.0% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.